Clinical Research Directory

Inclusion Criteria: 1. Patients with Crohn Disease (CD) diagnosed within 12 months before acceptance of clinical, endoscopical, anatomopathological and/or radiological criteria and have a non-active CD. (Crohn´s Disease Activity Index (CDAI)≤ 200) 2. Any gender, \> 18 Years of age 3. Negative pregnancy test in female subjects 4. Patients voluntarily sign the informed consent before performance of any study-related procedures 5. Patient is, in the investigator's opinion, willing and able to comply with the protocol requirements Exclusion Criteria: 1. Patients who have received infliximab or any other anti-TNF agent within 8 weeks before the cell treatment administration. 2. Patients who have received tacrolimus or cyclosporine within 4 weeks before cell treatment. 3. Patients with a history of alcohol or other addictive substance abuse within 6 months before inclusion. 4. Severe uncontrolled diseases (chronic renal failure, cardio, pulmonary, etc.). 5. Any type of medical or psychiatric disease which are considered an exclusion criterion, in the investigator's opinion. 6. Patients with a diagnosis of malignant neoplasia, except basal cell or epidermoid carcinoma of the skin, or a previous history of malignant tumors, except those that have no evidence of relapse for at least 5 years. 7. Subjects with congenital or acquired immunodeficiency. 8. Subjects who tested positive for HIV 1/2, HBV, HCV, HTLV I/II, WNV, and syphilis 9. Flu symptoms 10. Patient had major surgery or serious trauma within 6 weeks before enrolment. 11. Pregnant or breastfeeding women. 12. Physical or psychological impossibility of following the protocol requirements 13. Patients who are receiving or have received another investigational drug within 30 days prior to the first visit.